According to the Zhitong Finance App, Haite Biotech (300683.SZ) released its report for the first quarter of 2024. The company's revenue was 132 million yuan, a year-on-year decrease of 4.87%. The net loss attributable to shareholders of listed companies was 165.455 million yuan, an increase of 1024.00% over the previous year. Net loss attributable to shareholders of listed companies after deducting non-recurring profit and loss was RMB 22.6352 million, an increase of 186.72% over the previous year. The basic loss per share was $0.13.